Biggest News Aggregation in the World
📰 Aldx News

Page 4 - Aldx News Today

Fast, Ad-Free News Updates

Stay updated with breaking news from Aldx. Real-time updates on events, politics, business and more.

Aldeyra Therapeutics (NASDAQ:ALDX) Research Coverage Started at StockNews.com

StockNews.com assumed coverage on shares of Aldeyra Therapeutics (NASDAQ:ALDX – Get Rating) in a research note issued to investors on Thursday morning. The brokerage issued a hold rating on the biotechnology company’s stock. A number of other research analysts also recently weighed in on the company. Citigroup increased their target price on Aldeyra Therapeutics from […]
Aldeyra Therapeutics Company Profile Dorsey Wright Associates Barclays Plc Josephp Lucia Associates Cubist Systematic Strategies Tower Research Capital

Aldeyra Therapeutics (NASDAQ:ALDX) versus Cyclacel Pharmaceuticals (NASDAQ:CYCC) Financial Survey

Aldeyra Therapeutics (NASDAQ:ALDX – Get Rating) and Cyclacel Pharmaceuticals (NASDAQ:CYCC – Get Rating) are both small-cap medical companies, but which is the superior investment? We will contrast the two businesses based on the strength of their analyst recommendations, risk, valuation, dividends, earnings, profitability and institutional ownership. Volatility and Risk Aldeyra Therapeutics has a beta of […]
Ronaldj Berenson Cyclacel Pharmaceuticals Inc Cyclacel Pharmaceuticals Aldeyra Therapeutics Get Rating Cyclacel Pharmaceutical
Source: wkrb13.com

Aldeyra Therapeutics (NASDAQ:ALDX) Coverage Initiated at StockNews.com

Stock analysts at StockNews.com assumed coverage on shares of Aldeyra Therapeutics (NASDAQ:ALDX – Get Rating) in a research report issued to clients and investors on Thursday. The brokerage set a “hold” rating on the biotechnology company’s stock. Other equities research analysts have also issued reports about the company. HC Wainwright reaffirmed a “buy” rating and […]
Schonfeld Strategic Advisors Aldeyra Therapeutics Company Profile Geode Capital Management Squarepoint Ops Cubist Systematic Strategies Aldeyra Therapeutics
Source: wkrb13.com

Aldeyra Therapeutics (NASDAQ:ALDX) Stock Price Passes Above 50-Day Moving Average of $9.35

Aldeyra Therapeutics, Inc (NASDAQ:ALDX – Get Rating) crossed above its 50 day moving average during trading on Monday . The stock has a 50 day moving average of $9.35 and traded as high as $10.33. Aldeyra Therapeutics shares last traded at $10.21, with a volume of 450,195 shares changing hands. Analysts Set New Price Targets […]
Geode Capital Management Schonfeld Strategic Advisors Aldeyra Therapeutics Inc Cubist Systematic Strategies Aldeyra Therapeutics Company Profile Squarepoint Ops

Stay Updated with Latest News

Get breaking news updates delivered to your inbox

Browse All News →

Aldeyra Therapeutics (NASDAQ:ALDX) Announces Earnings Results, Beats Expectations By $0.03 EPS

Aldeyra Therapeutics (NASDAQ:ALDX – Get Rating) issued its quarterly earnings data on Thursday. The biotechnology company reported ($0.27) earnings per share (EPS) for the quarter, beating the consensus estimate of ($0.30) by $0.03, reports. Aldeyra Therapeutics Price Performance Shares of NASDAQ:ALDX traded up $0.18 during trading on Friday, hitting $10.57. 660,942 shares of the company’s […]
International Assets Investment Management Raymond James Associates Vontobel Holding Ltd Dorsey Wright Associates Aldeyra Therapeutics Get Rating
Source: wkrb13.com

Aldeyra Therapeutics, Inc (NASDAQ:ALDX) Short Interest Down 13.2% in April

Aldeyra Therapeutics, Inc (NASDAQ:ALDX – Get Rating) was the target of a large decline in short interest in the month of April. As of April 15th, there was short interest totalling 2,620,000 shares, a decline of 13.2% from the March 31st total of 3,020,000 shares. Based on an average trading volume of 749,600 shares, the […]
York Mellon Corp Raymond James Associates Vanguard Group Inc Aldeyra Therapeutics Company Profile Aldeyra Therapeutics Inc Jpmorgan Chase Co
Source: wkrb13.com

Aldeyra Therapeutics (ALDX) Set to Announce Quarterly Earnings on Wednesday

Aldeyra Therapeutics (NASDAQ:ALDX – Get Rating) will post its quarterly earnings results on Wednesday, May 3rd. Aldeyra Therapeutics Price Performance Shares of ALDX remained flat at $10.08 during midday trading on Tuesday. The stock had a trading volume of 287,184 shares, compared to its average volume of 693,791. The company has a market cap of […]
Millennium Management Goldman Sachs Group Inc Verition Fund Management Aldeyra Therapeutics Get Rating Sachs Group

Aldeyra Therapeutics (ALDX) Scheduled to Post Earnings on Wednesday

Aldeyra Therapeutics (NASDAQ:ALDX – Get Rating) is scheduled to issue its quarterly earnings data on Wednesday, May 3rd. Aldeyra Therapeutics Price Performance NASDAQ:ALDX traded down $0.03 during mid-day trading on Tuesday, reaching $10.05. The stock had a trading volume of 308,941 shares, compared to its average volume of 694,150. The stock has a market capitalization […]
Thrivent Financial For Lutherans Laidlaw Wealth Management Prudential Financial Inc Aldeyra Therapeutics Company Profile Man Group Capital Management

Explore More Categories

World News India News Business Technology Sports Entertainment Health Science